Home
>
National Drug Code (NDC)
>
Deferoxamine mesylate
Deferoxamine mesylate - 55390-265-01 - (deferoxamine mesylate)
Drug Information of Deferoxamine mesylate
| Product NDC: | 55390-265 |
| Proprietary Name: | Deferoxamine mesylate |
| Non Proprietary Name: | deferoxamine mesylate |
| Active Ingredient(s): | 2 g/21.1mL & nbsp; deferoxamine mesylate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Deferoxamine mesylate
| Product NDC: | 55390-265 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078086 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100618 |
Package Information of Deferoxamine mesylate
| Package NDC: | 55390-265-01 |
| Package Description: | 1 VIAL in 1 BOX (55390-265-01) > 20 mL in 1 VIAL |
NDC Information of Deferoxamine mesylate
| NDC Code | 55390-265-01 |
| Proprietary Name | Deferoxamine mesylate |
| Package Description | 1 VIAL in 1 BOX (55390-265-01) > 20 mL in 1 VIAL |
| Product NDC | 55390-265 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | deferoxamine mesylate |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20100618 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | DEFEROXAMINE MESYLATE |
| Strength Number | 2 |
| Strength Unit | g/21.1mL |
| Pharmaceutical Classes | Iron Chelating Activity [MoA],Iron Chelator [EPC] |
